Pelthos Therapeutics Expands BOD with the Appointment of Andrew Einhorn
Seasoned executive brings four decades of finance, capital markets, and life sciences experience Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing...